Trends in mortality related to venous thromboembolism in the European Union, 2012-2020.
Europe
Mortality
Trend
Venous thromboembolism
Journal
Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418
Informations de publication
Date de publication:
06 Mar 2024
06 Mar 2024
Historique:
received:
18
11
2023
accepted:
18
01
2024
medline:
7
3
2024
pubmed:
7
3
2024
entrez:
6
3
2024
Statut:
aheadofprint
Résumé
We sought to assess the sex- and age-specific trends in venous thromboembolism (VTE) mortality in the 27 European Union Member States (EU-27) between years 2012 and 2020. Data on cause-specific deaths and population numbers by sex for each country of the EU-27 were retrieved through the publicly available European Statistical Office (EUROSTAT) dataset for the years 2012-2020. VTE-related deaths were ascertained when ICD-10 codes I26, I80, and I82.9 were listed as the primary cause of death in the medical death certificate. To calculate annual trends, we assessed the average annual percent change (AAPC) with relative 95% confidence intervals (CIs) using Joinpoint regression. During the study period, 96,037 (55,278 males and 40,759 females) died for VTE. The age-adjusted mortality rate (AAMR) linearly declined from 2.86 (95% CI 2.84-2.90) deaths per 100,000 individuals in 2012 to 2.53 (95% CI 2.50-2.56) deaths per 100,000 population in 2020 [AAPC: - 2.1% (95% CI - 3.6 to - 0.6), p = 0.001] without differences between sexes (p = 0.60). The higher AAMR was observed in some eastern European countries such as Bulgaria, Czech Republic, and Lithuania. On the contrary, the lower AAMR was mainly clustered in the Mediterranean area (Italy, Spain, and Cyprus). Over the last decade, the age-adjusted VTE-related mortality has been continuously declining in most of the in EU-27 Member States. However, some disparities still exist between western and eastern European countries.
Identifiants
pubmed: 38448688
doi: 10.1007/s11739-024-03550-6
pii: 10.1007/s11739-024-03550-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI).
Références
Glynn RJ, Rosner B (2005) Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 162:975–982
doi: 10.1093/aje/kwi309
pubmed: 16207808
Cohen AT, Agnelli G, Anderson FA et al (2007) Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 98:756–764
doi: 10.1160/TH07-03-0212
pubmed: 17938798
Heit JA (2008) The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 28:370–372
doi: 10.1161/ATVBAHA.108.162545
pubmed: 18296591
pmcid: 2873781
Lutsey PL, Zakai NA (2023) Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol 20:248–262
doi: 10.1038/s41569-022-00787-6
pubmed: 36258120
Keller K, Hobohm L, Ebner M, Kresoja KP, Münzel T, Konstantinides SV, Lankeit M (2020) Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J 41:522–529
doi: 10.1093/eurheartj/ehz236
pubmed: 31102407
Willich SN, Chuang LH, van Hout B, Gumbs P, Jimenez D, Kroep S, Bauersachs R, Monreal M, Agnelli G, Cohen A (2018) Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to work. Thromb Res 170:181–191
doi: 10.1016/j.thromres.2018.02.009
pubmed: 30199784
Balachandran A, de Beer J, James KS, van Wissen L, Janssen F (2020) Comparison of population aging in europe and asia using a time-consistent and comparative aging measure. J Aging Health 32:340–351
doi: 10.1177/0898264318824180
pubmed: 30651037
Engbers MJ, van Hylckama VA, Rosendaal FR (2010) Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 8:2105–2112
doi: 10.1111/j.1538-7836.2010.03986.x
pubmed: 20629943
Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, Gavin A, Flego M, Neamtiu L, Dimitrova N, Negrão Carvalho R, Ferlay J, Bettio M (2021) The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer 157:308–347
doi: 10.1016/j.ejca.2021.07.039
pubmed: 34560371
pmcid: 8568058
Berghöfer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN (2008) Obesity prevalence from a European perspective: a systematic review. BMC Public Health 8:200
doi: 10.1186/1471-2458-8-200
pubmed: 18533989
pmcid: 2441615
Willame C, Dodd C, van der Aa L, Picelli G, Emborg HD, Kahlert J, Gini R, Huerta C, Martín-Merino E, McGee C, de Lusignan S, Roberto G, Villa M, Weibel D, Titievsky L, Sturkenboom MCJM (2021) Incidence rates of autoimmune diseases in european healthcare databases: a contribution of the ADVANCE project. Drug Saf 44:383–395
doi: 10.1007/s40264-020-01031-1
pubmed: 33462778
pmcid: 7892524
Khialani D, Jones ME, Szépligeti SK, Ording AG, Ehrenstein V, Petersen I, van Hylckama VA (2020) Combined hormonal contraceptive use in Europe before and after the European Commission mandated changes in product information. Contracept X 2:100018
doi: 10.1016/j.conx.2020.100018
pubmed: 32550533
pmcid: 7286180
Barco S, Mahmoudpour SH, Valerio L, Klok FA, Münzel T, Middeldorp S, Ageno W, Cohen AT, Hunt BJ, Konstantinides SV (2020) Trends in mortality related to pulmonary embolism in the European Region, 2000–15: analysis of vital registration data from the WHO Mortality Database. Lancet Respir Med 8:277–287
doi: 10.1016/S2213-2600(19)30354-6
pubmed: 31615719
Barco S, Valerio L, Gallo A, Turatti G, Mahmoudpour SH, Ageno W, Castellucci LA, Cesarman-Maus G, Ddungu H, De Paula EV, Dumantepe M, Goldhaber SZ, Guillermo Esposito MC, Klok FA, Kucher N, McLintock C, Ní Áinle F, Simioni P, Spirk D, Spyropoulos AC, Urano T, Zhai ZG, Hunt BJ, Konstantinides SV (2021) Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countries. Res Pract Thromb Haemost 5:e12520
doi: 10.1002/rth2.12520
pubmed: 34263098
pmcid: 8268665
https://ec.europa.eu/eurostat/data/database [Accessed 14 March 2023]
https://ec.europa.eu/eurostat/cache/metadata/en/demo_mor_esms.htm [Accessed 14 March 2023]
https://ec.europa.eu/eurostat/web/products-manuals-and-guidelines/-/ks-ra-13-028 [Accessed 14 March 2023]
Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M, Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35:3033–69
doi: 10.1093/eurheartj/ehu283
pubmed: 25173341
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL, Van Belle E, Zamorano JL; ESC Scientific Document Group (2020) 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41:543–603
doi: 10.1093/eurheartj/ehz405
pubmed: 31504429
National Cancer Institute. Number of Joipoints. Available at: https://surveillance.cancer.gov/help/joinpoint/setting-parameters/method-and-parameters-tab/number-of-joinpoints [Accessed March 29,2023]
Kim HJ, Fay MP, Yu B, Barrett MJ, Feuer EJ (2004) Comparability of segmented line regression models. Biometrics 60:1005–1014
doi: 10.1111/j.0006-341X.2004.00256.x
pubmed: 15606421
Weitz JI, Chan NC (2020) Novel antithrombotic strategies for treatment of venous thromboembolism. Blood 135:351–359
doi: 10.1182/blood.2019000919
pubmed: 31917385
Elmi G, Pizzini AM, Silingardi M (2018) The secondary prevention of venous thromboembolism: towards an individual therapeutic strategy. Vascular 26:670–682
doi: 10.1177/1708538118776896
pubmed: 29966487
Di Fazio N, Delogu G, Ciallella C, Padovano M, Spadazzi F, Frati P, Fineschi V (2021) State-of-art in the age determination of venous thromboembolism: a systematic review. Diagnostics (Basel) 11:2397
doi: 10.3390/diagnostics11122397
pubmed: 34943633
Farge D, Frere C, Connors JM, Khorana AA, Kakkar A, Ay C, Muñoz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-García LA, Bounameaux H, Pabinger I, Douketis J, International Initiative on Thrombosis and Cancer (ITAC) advisory panel (2022) 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol 23:e334–e347
doi: 10.1016/S1470-2045(22)00160-7
pubmed: 35772465
pmcid: 9236567
Duranteau J, Taccone FS, Verhamme P, Ageno W, ESA VTE Guidelines Task Force (2018) European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care. Eur J Anaesthesiol 35:142–146
doi: 10.1097/EJA.0000000000000707
pubmed: 29112545
Van Es N, van der Hulle T, van Es J, den Exter PL, Douma RA, Goekoop RJ, Mos IC, Galipienzo J, Kamphuisen PW, Huisman MV et al (2016) Wells rule and D-dimer testing to rule out pulmonary embolism: a systematic review and individual-patient data meta-analysis. Ann Intern Med 165:253–261
doi: 10.7326/M16-0031
pubmed: 27182696
Righini M, Robert-Ebadi H, Le Gal G (2017) Diagnosis of acute pulmonary embolism. J Thromb Haemost 15:1251–1261
doi: 10.1111/jth.13694
pubmed: 28671347
Heit JA (2015) Epidemiology of venous thromboembolism. Nat Rev Cardiol 12:464–474
doi: 10.1038/nrcardio.2015.83
pubmed: 26076949
pmcid: 4624298
Santucci C, Patel L, Malvezzi M, Wojtyla C, La Vecchia C, Negri E, Bertuccio P (2022) Persisting cancer mortality gap between western and eastern Europe. Eur J Cancer 165:1–12
doi: 10.1016/j.ejca.2022.01.007
pubmed: 35189536
Lind MM, Johansson M, Själander A, Johansson L (2022) Incidence and risk factors of venous thromboembolism in men and women. Thromb Res 214:82–86
doi: 10.1016/j.thromres.2022.04.014
pubmed: 35523076
Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P et al (2004) Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 117:19–25
doi: 10.1016/j.amjmed.2004.01.018
pubmed: 15210384
Severinsen MT, Johnsen SP, Tjønneland A, Overvad K, Dethlefsen C, Kristensen SR (2010) Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study. Eur J Intern Med 21:268–272
doi: 10.1016/j.ejim.2010.03.013
pubmed: 20603033
Loichinger E, Weber D (2016) Trends in working life expectancy in Europe. J Aging Health 28:1194–1213
doi: 10.1177/0898264316656509
pubmed: 27590798
Arnesen CAL, Veres K, Horváth-Puhó E, Hansen JB, Sørensen HT, Brækkan SK (2022) Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death. Eur J Epidemiol 37:195–203
doi: 10.1007/s10654-021-00813-w
pubmed: 34746973
Marshall AL, Bartley AC, Ashrani AA, Pruthi RK, Durani U, Gonsalves WI, Kapoor P, Hashmi SK, Siddiqui MA, Go RS (2017) Sex-based disparities in venous thromboembolism outcomes: a National Inpatient Sample (NIS)-based analysis. Vasc Med 22:121–127
doi: 10.1177/1358863X17693103
pubmed: 28429667
Giannis D, Barish MA, Goldin M, Cohen SL, Kohn N, Gianos E, Chatterjee S, Lesser M, Coppa K, Hirsch JS, McGinn T, Spyropoulos AC, COVID-19 Consortium Group (2021) Incidence of venous thromboembolism and mortality in patients with initial presentation of COVID-19. J Thromb Thrombolysis 51:897–901
doi: 10.1007/s11239-021-02413-7
pubmed: 33665766
pmcid: 7932762
Zuin M, Barco S, Giannakoulas G, Engelen MM, Hobohm L, Valerio L, Vandenbriele C, Verhamme P, Vanassche T, Konstantinides SV (2023) Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis. J Thromb Thrombolysis 55:490–498
doi: 10.1007/s11239-022-02766-7
pubmed: 36652137
pmcid: 9845812
Fang MC, Reynolds K, Tabada GH, Prasad PA, Sung SH, Parks AL, Garcia E, Portugal C, Fan D, Pai AP, Go AS (2023) Assessment of the risk of venous thromboembolism in nonhospitalized patients with COVID-19. JAMA Netw Open 6:e232338
doi: 10.1001/jamanetworkopen.2023.2338
pubmed: 36912838
pmcid: 10011935
Öhman L, Johansson M, Jansson JH, Lind M, Johansson L (2018) Positive predictive value and misclassification of diagnosis of pulmonary embolism and deep vein thrombosis in Swedish patient registries. Clin Epidemiol 10:1215–1221
doi: 10.2147/CLEP.S177058
pubmed: 30271217
pmcid: 6147534
Burles K, Innes G, Senior K, Lang E, McRae A (2017) Limitations of pulmonary embolism ICD-10 codes in emergency department administrative data: let the buyer beware. BMC Med Res Methodol 17:89
doi: 10.1186/s12874-017-0361-1
pubmed: 28595574
pmcid: 5465555
White RH, Garcia M, Sadeghi B, Tancredi DJ, Zrelak P, Cuny J, Sama P, Gammon H, Schmaltz S, Romano PS (2010) Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States. Thromb Res 126:61–67
doi: 10.1016/j.thromres.2010.03.009
pubmed: 20430419
Lloyd-Jones DM, Martin DO, Larson MG, Levy D (1998) Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 129:1020–1026
doi: 10.7326/0003-4819-129-12-199812150-00005
pubmed: 9867756